← European Medicine Shortage Tracker · all medicines
Availability information only — Mobi Doctor doesn't sell medicines; check with a pharmacy.
Repaglinid currently has availability issues reported in 3 European registers: Spain, Greece, Sweden.
Shortage ATC A10BX02 · also listed as: REPAGLINIDA · REPAGLINIDE · repaglinid · data refreshed 14 September 2026
As of 14 September 2026, 3 of the 9 tracked registers list current availability issues for Repaglinid, covering 15 affected product presentations. The longest-running open report was filed in Sweden on 2026-02-17 and has now been open for about 7 months. Where agencies state a cause, delivery delays lead with 1 of the 1 stated-cause reports. The furthest expected-resolution date currently on file is 2026-12-31; the earliest is 2026-09-17. Notably, 2 reports have already passed the expected-resolution date without closing — prognoses for this medicine should be read as estimates, not commitments. Momentum is current, not historical: 9 of the open reports were filed within the last 90 days. The issue spread across registers over time rather than at once: Sweden reported first (2026-02-17), with Greece following roughly 5 months later — a pattern typical of supply problems cascading between national markets. Registers in Spain, Sweden indicate that alternatives or equivalents are available — a pharmacist or doctor can advise on switching. In the WHO ATC classification, Repaglinid is coded A10BX02 — a medicine acting on alimentary tract and metabolism — so clinically related products appear under “Related medicines” below.
| Where | Status & products | Since | Expected end | Reason / alternatives | Source |
|---|---|---|---|---|---|
| 🇪🇸 Spain | Shortage REPAGLINIDA KERN PHARMA 1 mg COMPRIMIDOS EFG, 90 comprimidos | 2026-06-29 | — | Existen otros medicamentos con el mismo principio activo y misma vía. Alternatives: Existe/n otro/s medicamento/s con el mismo principio activo y para la misma vía de administración. | register ↗ |
| 🇬🇷 Greece | Limited availability NOVONORM TABLET 2MG/TAB BLIST.(alu/alu)X120 | 2026-07-12 | 2026-08-31 | Καθυστέρηση παράδοσης Εναλλακτικά το ίδιο φάρμακο σε διαφορετική περιε | register ↗ |
| 🇸🇪 Sweden | Shortage Repaglinid Actavis 0,5 mg Tablett + 12 more productsRepaglinid Actavis 1 mg Tablett Repaglinid Actavis 2 mg Tablett Repaglinid Actavis 2 mg Tablett Repaglinid STADA 0,5 mg Tablett Repaglinid STADA 1 mg Tablett Repaglinid STADA 1 mg Tablett Repaglinid STADA 2 mg Tablett Repaglinide Krka 0,5 mg Tablett Repaglinide Krka 0,5 mg Tablett Repaglinide Krka 1 mg Tablett Repaglinide Krka 1 mg Tablett Repaglinide Krka 2 mg Tablett | 2026-02-17 | 2026-12-31 | — Alternatives: Alternative(s) available — see the national register. | register ↗ |
Every individual register entry for Repaglinid in the tracked sources, newest first — including resolved and discontinued reports.
| Reg. | Product | Status | Reported | Expected end | Stated reason |
|---|---|---|---|---|---|
| 🇸🇪 SE | Repaglinid Actavis 2 mg Tablett | Expected shortage | 2026-08-24 | 2026-10-07 | |
| 🇸🇪 SE | Repaglinide Krka 2 mg Tablett | Expected shortage | 2026-08-15 | 2026-10-01 | |
| 🇸🇪 SE | Repaglinid STADA 1 mg Tablett | Expected shortage | 2026-08-10 | 2026-10-10 | |
| 🇸🇪 SE | Repaglinid STADA 2 mg Tablett | Expected shortage | 2026-08-10 | 2026-10-10 | |
| 🇸🇪 SE | Repaglinide Krka 1 mg Tablett | Expected shortage | 2026-08-08 | 2026-10-08 | |
| 🇸🇪 SE | Repaglinide Krka 1 mg Tablett | Expected shortage | 2026-08-08 | 2026-10-02 | |
| 🇬🇷 GR | NOVONORM TABLET 2MG/TAB BLIST.(alu/alu)X120 | Limited availability | 2026-07-12 | 2026-08-31 | Καθυστέρηση παράδοσης Εναλλακτικά το ίδιο φάρμακο σε διαφορε |
| 🇪🇸 ES | REPAGLINIDA KERN PHARMA 1 mg COMPRIMIDOS EFG, 90 comprimidos | Shortage | 2026-06-29 | — | Existen otros medicamentos con el mismo principio activo y m |
| 🇸🇪 SE | Repaglinid STADA 1 mg Tablett | Shortage | 2026-06-25 | 2026-10-10 | |
| 🇸🇪 SE | Repaglinid Actavis 2 mg Tablett | Shortage | 2026-06-10 | 2026-10-09 | |
| 🇸🇪 SE | Repaglinide Krka 0,5 mg Tablett | Shortage | 2026-05-01 | 2026-10-01 | |
| 🇸🇪 SE | Repaglinide Krka 0,5 mg Tablett | Shortage | 2026-04-10 | 2026-09-17 | |
| 🇸🇪 SE | Repaglinid STADA 0,5 mg Tablett | Shortage | 2026-04-06 | 2026-08-31 | |
| 🇸🇪 SE | Repaglinid Actavis 0,5 mg Tablett | Shortage | 2026-02-17 | 2026-12-31 | |
| 🇸🇪 SE | Repaglinid Actavis 1 mg Tablett | Shortage | 2026-02-17 | 2026-12-31 |
Yes. As of 14 September 2026, availability issues are reported in: Spain, Greece, Sweden. Availability is national — a shortage in one country does not mean it is short everywhere.
Agency prognoses on file range from 2026-09-17 to 2026-12-31. These are manufacturer-reported estimates and frequently move; check the linked register entry for the latest date.
14 of the active register entries indicate alternatives or equivalents (same active substance or an alternative treatment). Do not switch on your own — a pharmacist or prescriber can confirm the right substitute in your country.
Directly from the official medicines-agency registers that list Repaglinid: AEMPS CIMA (Spain), EOF limited-availability list (Greece), Läkemedelsverket (Sweden). Every row on this page links to the underlying official record, and the dataset is refreshed from the primary sources every morning. Cross-language matching groups the same active substance across registers, so national spellings all resolve to this page.
Pharmacies, patient sites and newsrooms are welcome to embed the live status of Repaglinid — free, with attribution. Copy this snippet:
<iframe src="https://www.mobidoctor.eu/medicine-shortages/medicine-shortages/repaglinid/embed.html" width="100%" height="150" loading="lazy" style="border:1px solid #e1e0d9;border-radius:12px" title="Repaglinid availability in Europe"></iframe> <p style="font-size:12px">Source: <a href="https://www.mobidoctor.eu/medicine-shortages/medicine-shortages/repaglinid/">Repaglinid shortage status — European Medicine Shortage Tracker</a> by MobiDoctor</p>